Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study.
about
Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.Targeting Rho-GTPases in immune cell migration and inflammation.Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit.Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions.Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration.The role of the host defense system in the development of cerebral vasospasm: analogies between atherosclerosis and subarachnoid hemorrhage.Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage.Current management of delayed cerebral ischemia: update from results of recent clinical trials.Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivoMyosin IXa regulates epithelial differentiation and its deficiency results in hydrocephalus.Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling.Endothelial Permeability, Ldl Deposition, and Cardiovascular Risk Factors - A Review.Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.Stimulation of norepinephrine transporter function by fasudil, a Rho kinase inhibitor, in cultured bovine adrenal medullary cells.Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injuryRotavirus-Induced Early Activation of the RhoA/ROCK/MLC Signaling Pathway Mediates the Disruption of Tight Junctions in Polarized MDCK Cells
P2860
Q28274176-92A4F2A6-35EF-429C-B3A6-7A9ECE16FF74Q33918485-CED27DCE-BC6C-4DD9-9B8F-29247C198FC0Q34362144-1913AE95-C177-4D3E-A417-CB839430AE87Q34451923-F6F76685-0C79-4A26-885E-592B962BF15CQ34803380-B347B535-F12B-443C-83FE-06B2ECC2BB87Q34823543-F7267AD3-F966-44E6-8DE0-D7DC77E187D1Q35847696-A2D250AF-2006-486D-9F32-BE8DDD173F71Q36816542-22A655A2-A990-4076-8122-09BD42100ABFQ36831190-9B2AB571-46AB-4581-BD46-70F082F94ADFQ37450106-5B3CF3C4-91A9-470C-9190-9511909C0F92Q37953906-CB31B3E5-0247-4AEF-B9F4-EDE4EE74C79CQ38055310-4E466CBF-1B12-4F02-905B-FDD53144F697Q38086608-F178F552-8EB9-4316-A826-A3992401F8DBQ38166813-D123315E-25CE-4C03-A1DC-495DD9633485Q38171354-7812C20A-7A10-4441-98D9-B86BBC4F0C1FQ38951511-0BADA5CD-6906-4D37-8554-C22619591E69Q42069362-EFA41DF9-181C-4465-A32D-BDBA169F1460Q42953653-EECE756C-4F3A-4193-AB84-A793D2C1F831Q43530084-7AF3D983-D71F-4001-A3C1-94A62934CFE4Q46059179-C8FC3A7D-5E17-4288-96BF-42E1950A2BFCQ50356583-0521FEAF-2830-4B57-B6D5-99350DCFEA45Q54500332-59B63B33-8737-40EB-BD27-DB97A26BC770Q57839498-92E9E860-F5B2-44C7-AD7D-F02CD618730BQ58734316-33D4B8AB-6939-4332-AC00-61AB53ED1F06
P2860
Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Safety and efficacy of fasudil ...... -marketing surveillance study.
@en
Safety and efficacy of fasudil ...... -marketing surveillance study.
@nl
type
label
Safety and efficacy of fasudil ...... -marketing surveillance study.
@en
Safety and efficacy of fasudil ...... -marketing surveillance study.
@nl
prefLabel
Safety and efficacy of fasudil ...... -marketing surveillance study.
@en
Safety and efficacy of fasudil ...... -marketing surveillance study.
@nl
P2093
P356
P1476
Safety and efficacy of fasudil ...... -marketing surveillance study.
@en
P2093
Hirotoshi Sugiyama
Kintomo Takakura
Masato Shibuya
Minoru Seto
Shin-ichi Satoh
Yoshio Suzuki
P304
241-7; discussion 247-8
P356
10.2176/NMC.48.241
P577
2008-06-01T00:00:00Z